ReviewJournal of migration and health2025
Global burden of cancer among refugees: A systematic review and meta-analysis.
Review in Journal of migration and health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Stocktaking of the progress towards the implementation of the global manifesto on improving cancer care in conflict-impacted populations.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Refugees are a distinct group of migrants with a variety of cancer risks through cumulative exposures from their country of origin, migration process, and host countries. We conducted a comprehensive systematic synthesis of the epidemiological burden (incidence, prevalence, and mortality) of overall and site specific cancers among refugee populations globally. Method: We systematically searched in OVID (Medline, Embase), CINAHL, and Scopus for studies reporting cancer prevalence, incidence, or mortality data among refugees globally from database inception to December 15, 2023. We screened for eligible studies using Covidence®. We applied a random-effects model to estimate the pooled proportions of site-specific cancer proportions using R software. Result: Twenty-nine studies from 12 host countries comprising 561,850 refugees, mainly from Syria and Iraq were included. The pooled proportions for commonly reported site-specific cancer among refugee cancer patients were breast cancer (25.4% (95% CI: 20.3%, 30.4%)), lung cancer (4.8% (95% CI: 3.9%, 5.6%)), leukaemia (16.9% (95% CI: 8.2%, 25.6%)), and central nervous system (CNS) cancer (7.0% (95% CI: 5.3%, 8.7%)) respectively. Studies also reported a higher cervical cancer incidence among female refuges and higher liver cancer mortality among male refugees than non-refugee populations. Conclusion: Although the existing evidence is limited, this review highlights a notable cancer burden among refugees, with higher incidence and mortality for certain cancers such as cervical and liver cancer among refugees than non-refugees. Targeted practical initiatives in ensuring optimal cancer continuum of care for refugees with cross-disciplinary collaboration are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.